UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
20.44
-0.03 (-0.15%)
Nov 3, 2025, 1:01 PM EST - Market open
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $945.64 million as of November 3, 2025. Its market cap has increased by 78.22% in one year.
Market Cap
945.64M
Enterprise Value
912.91M
1-Year Change
78.22%
Ranking
Category
Stock Price
$20.44
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $181.90M to $945.64M, an increase of 419.87%. That is a compound annual growth rate of 21.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 947.00M | 110.73% |
| Dec 31, 2024 | 449.40M | -2.94% |
| Dec 29, 2023 | 463.00M | 126.07% |
| Dec 30, 2022 | 204.80M | -3.94% |
| Dec 31, 2021 | 213.20M | -46.45% |
| Dec 31, 2020 | 398.10M | -43.14% |
| Dec 31, 2019 | 700.10M | 18.24% |
| Dec 31, 2018 | 592.10M | 22.31% |
| Dec 29, 2017 | 484.10M | 166.14% |
| May 4, 2017 | 181.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |